{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:36:34Z","timestamp":1785800194063,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Amgen Korea Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00774-021-01259-6","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T07:12:04Z","timestamp":1629702724000},"page":"109-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment pattern in postmenopausal women with osteoporosis: a population-based cohort study in South Korea"],"prefix":"10.1007","volume":"40","author":[{"given":"Ju Hwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Eol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuna","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","volume":"90","author":"A Singer","year":"2015","unstructured":"Singer A, Exuzides A, Spangler L, O\u2019Malley C, Colby C, Johnston K, Agodoa I, Baker J, Kagan R (2015) Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc 90:53\u201362. https:\/\/doi.org\/10.1016\/j.mayocp.2014.09.011","journal-title":"Mayo Clin Proc"},{"key":"1259_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1055\/s-0034-1384629","volume":"32","author":"RD Jackson","year":"2014","unstructured":"Jackson RD, Mysiw WJ (2014) Insights into the epidemiology of postmenopausal osteoporosis: the Women\u2019s Health Initiative. Semin Reprod Med 32:454\u2013462. https:\/\/doi.org\/10.1055\/s-0034-1384629","journal-title":"Semin Reprod Med"},{"key":"1259_CR3","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"1259_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/jbmr.1635","volume":"27","author":"YJ Choi","year":"2012","unstructured":"Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS (2012) The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008\u20132009. J Bone Miner Res 27:1879\u20131886. https:\/\/doi.org\/10.1002\/jbmr.1635","journal-title":"J Bone Miner Res"},{"key":"1259_CR5","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520\u20132526. https:\/\/doi.org\/10.1002\/jbmr.2269","journal-title":"J Bone Miner Res"},{"key":"1259_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022. https:\/\/doi.org\/10.4065\/81.8.1013","journal-title":"Mayo Clin Proc"},{"key":"1259_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11657-018-0443-7","volume":"13","author":"S Fujiwara","year":"2018","unstructured":"Fujiwara S, Miyauchi A, Hamaya E, Nicholls RJ, Weston A, Baidya S, Pinto L, Barron R, Takada J (2018) Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review. Arch Osteoporos 13:34. https:\/\/doi.org\/10.1007\/s11657-018-0443-7","journal-title":"Arch Osteoporos"},{"key":"1259_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1532-5415.2006.00758.x","volume":"54","author":"M Melo","year":"2006","unstructured":"Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M (2006) Persistence with bisphosphonate therapy in older people. J Am Geriatr Soc 54:1015\u20131016. https:\/\/doi.org\/10.1111\/j.1532-5415.2006.00758.x","journal-title":"J Am Geriatr Soc"},{"key":"1259_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023\u20131031. https:\/\/doi.org\/10.1007\/s00198-006-0322-8","journal-title":"Osteoporos Int"},{"key":"1259_CR10","unstructured":"Park EC, Jang SI, Jeon SY, Lee SA, Lee JE, Choi DW (2017) Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database. Health Insurance Review & Assessment Service,"},{"issue":"Suppl","key":"1259_CR11","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.3346\/jkms.2012.27.S.S70","volume":"27","author":"HS Kim","year":"2012","unstructured":"Kim HS, Shin DW, Lee WC, Kim YT, Cho B (2012) National screening program for transitional ages in Korea: a new screening for strengthening primary prevention and follow-up care. J Korean Med Sci 27(Suppl):S70\u2013S75. https:\/\/doi.org\/10.3346\/jkms.2012.27.S.S70","journal-title":"J Korean Med Sci"},{"key":"1259_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, Kang HJ, Do CH, Song JS, Lee EJ, Ha S, Shin SA, Jeong SL (2017) Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 7:e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640","journal-title":"BMJ Open"},{"key":"1259_CR13","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","volume":"165","author":"DH Solomon","year":"2005","unstructured":"Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414\u20132419. https:\/\/doi.org\/10.1001\/archinte.165.20.2414","journal-title":"Arch Intern Med"},{"key":"1259_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/IJGM.S36944","volume":"6","author":"A Balasubramanian","year":"2013","unstructured":"Balasubramanian A, Brookhart MA, Goli V, Critchlow CW (2013) Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med 6:839\u2013848. https:\/\/doi.org\/10.2147\/IJGM.S36944","journal-title":"Int J Gen Med"},{"key":"1259_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00198-011-1645-7","volume":"23","author":"AM Burden","year":"2012","unstructured":"Burden AM, Paterson JM, Solomon DH, Mamdani M, Juurlink DN, Cadarette SM (2012) Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada. Osteoporos Int 23:1075\u20131082. https:\/\/doi.org\/10.1007\/s00198-011-1645-7","journal-title":"Osteoporos Int"},{"key":"1259_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bone.2013.09.008","volume":"57","author":"DK Wysowski","year":"2013","unstructured":"Wysowski DK, Greene P (2013) Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002\u20132012. Bone 57:423\u2013428. https:\/\/doi.org\/10.1016\/j.bone.2013.09.008","journal-title":"Bone"},{"key":"1259_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2474-15-112","volume":"15","author":"H Yun","year":"2014","unstructured":"Yun H, Curtis JR, Guo L, Kilgore M, Muntner P, Saag K, Matthews R, Morrisey M, Wright NC, Becker DJ, Delzell E (2014) Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries. BMC Musculoskelet Disord 15:112. https:\/\/doi.org\/10.1186\/1471-2474-15-112","journal-title":"BMC Musculoskelet Disord"},{"key":"1259_CR18","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/jbmr.12","volume":"25","author":"FA Tremollieres","year":"2010","unstructured":"Tremollieres FA, Pouilles JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P (2010) Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool (in eng). J Bone Mineral Res: Off J Am Soc Bone Mineral Res 25:1002\u20131009. https:\/\/doi.org\/10.1002\/jbmr.12","journal-title":"J Bone Mineral Res: Off J Am Soc Bone Mineral Res"},{"key":"1259_CR19","unstructured":"National Osteoporosis Foundation: 2013 Clinician's Guide to Prevention and Treatment of Osteoporosis. (2013) National Osteoporosis Foundation."},{"key":"1259_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","volume":"13","author":"H Jiao","year":"2015","unstructured":"Jiao H, Xiao E, Graves DT (2015) Diabetes and its effect on bone and fracture healing (in eng). Curr Osteoporos Rep 13:327\u2013335. https:\/\/doi.org\/10.1007\/s11914-015-0286-8","journal-title":"Curr Osteoporos Rep"},{"key":"1259_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study (in eng). BMJ (Clinical research ed) 344:e3427. https:\/\/doi.org\/10.1136\/bmj.e3427","journal-title":"BMJ (Clinical research ed)"},{"key":"1259_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098043","volume":"9","author":"HA Kim","year":"2014","unstructured":"Kim HA, Shin JY, Kim MH, Park BJ (2014) Prevalence and predictors of polypharmacy among Korean elderly (in eng). PLoS ONE 9:e98043. https:\/\/doi.org\/10.1371\/journal.pone.0098043","journal-title":"PLoS ONE"},{"key":"1259_CR23","unstructured":"Szklo M, Nieto J (2007) Epidemiology: Beyond the Basics. Jones & Bartlett Learning"},{"key":"1259_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/2151458512454878","volume":"3","author":"LJ Gleason","year":"2012","unstructured":"Gleason LJ, Menzies IB, Mendelson DA, Kates SL, Friedman SM (2012) Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil 3:79\u201383. https:\/\/doi.org\/10.1177\/2151458512454878","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"1259_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1185\/03007995.2013.851074","volume":"30","author":"ES Siris","year":"2014","unstructured":"Siris ES, Modi A, Tang J, Gandhi S, Sen S (2014) Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis. Curr Med Res Opin 30:123\u2013130. https:\/\/doi.org\/10.1185\/03007995.2013.851074","journal-title":"Curr Med Res Opin"},{"key":"1259_CR26","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00198-017-4144-7","volume":"28","author":"C Reyes","year":"2017","unstructured":"Reyes C, Tebe C, Martinez-Laguna D, Ali MS, Soria-Castro A, Carbonell C, Prieto-Alhambra D (2017) One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. Osteoporos Int 28:2997\u20133004. https:\/\/doi.org\/10.1007\/s00198-017-4144-7","journal-title":"Osteoporos Int"},{"key":"1259_CR27","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/s0025-6196(11)61093-8","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82:1493\u20131501. https:\/\/doi.org\/10.1016\/s0025-6196(11)61093-8","journal-title":"Mayo Clin Proc"},{"key":"1259_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1185\/03007990903361307","volume":"25","author":"S Epstein","year":"2009","unstructured":"Epstein S, Jeglitsch M, McCloskey E (2009) Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. Curr Med Res Opin 25:2951\u20132960. https:\/\/doi.org\/10.1185\/03007990903361307","journal-title":"Curr Med Res Opin"},{"key":"1259_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11657-017-0316-5","volume":"12","author":"E Durden","year":"2017","unstructured":"Durden E, Pinto L, Lopez-Gonzalez L, Juneau P, Barron R (2017) Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States. Arch Osteoporos 12:22. https:\/\/doi.org\/10.1007\/s11657-017-0316-5","journal-title":"Arch Osteoporos"},{"key":"1259_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637\u2013645. https:\/\/doi.org\/10.1001\/jama.282.7.637","journal-title":"JAMA"},{"key":"1259_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-6874-13-15","volume":"13","author":"SA Foster","year":"2013","unstructured":"Foster SA, Shi N, Curkendall S, Stock J, Chu BC, Burge R, Diakun DR, Krege JH (2013) Fractures in women treated with raloxifene or alendronate: a retrospective database analysis. BMC Womens Health 13:15. https:\/\/doi.org\/10.1186\/1472-6874-13-15","journal-title":"BMC Womens Health"},{"key":"1259_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00774-010-0249-1","volume":"29","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Nakamura T, Hagino H, Fujiwara S, Lange JL, Watts NB (2011) Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. J Bone Miner Metab 29:561\u2013570. https:\/\/doi.org\/10.1007\/s00774-010-0249-1","journal-title":"J Bone Miner Metab"},{"key":"1259_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/gme.0b013e31820b80f1","volume":"18","author":"G Bachmann","year":"2011","unstructured":"Bachmann G, Kriegman A, Goncalves J, Kianifard F, Warren M, Simon JA (2011) Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density. Menopause 18:851\u2013856. https:\/\/doi.org\/10.1097\/gme.0b013e31820b80f1","journal-title":"Menopause"},{"key":"1259_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1472-6874-8-24","volume":"8","author":"SA Foster","year":"2008","unstructured":"Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR (2008) Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. BMC Womens Health 8:24. https:\/\/doi.org\/10.1186\/1472-6874-8-24","journal-title":"BMC Womens Health"},{"key":"1259_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11657-018-0528-3","volume":"13","author":"SD Berry","year":"2018","unstructured":"Berry SD, Dufour AB, Travison TG, Zhu H, Yehoshua A, Barron R, Recknor C, Samelson EJ (2018) Changes in bone mineral density (BMD): a longitudinal study of osteoporosis patients in the real-world setting. Arch Osteoporos 13:124. https:\/\/doi.org\/10.1007\/s11657-018-0528-3","journal-title":"Arch Osteoporos"},{"key":"1259_CR36","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74:1385\u20131393. https:\/\/doi.org\/10.1038\/ki.2008.356","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"1259_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1634\/theoncologist.9-90004-28","volume":"9","author":"P Conte","year":"2004","unstructured":"Conte P, Guarneri V (2004) Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 9(Suppl 4):28\u201337. https:\/\/doi.org\/10.1634\/theoncologist.9-90004-28","journal-title":"Oncologist"},{"key":"1259_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40266-019-00714-4","volume":"36","author":"HG Raterman","year":"2019","unstructured":"Raterman HG, Lems WF (2019) Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide (in eng). Drugs Aging 36:1061\u20131072. https:\/\/doi.org\/10.1007\/s40266-019-00714-4","journal-title":"Drugs Aging"},{"key":"1259_CR39","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/acr.21777","volume":"64","author":"JS Richards","year":"2012","unstructured":"Richards JS, Cannon GW, Hayden CL, Amdur RL, Lazaro D, Mikuls TR, Reimold AM, Caplan L, Johnson DS, Schwab P, Cherascu BN, Kerr GS (2012) Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis. Arthritis Care Res 64:1864\u20131870. https:\/\/doi.org\/10.1002\/acr.21777","journal-title":"Arthritis Care Res"},{"key":"1259_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jep.12095","volume":"20","author":"K Ladova","year":"2014","unstructured":"Ladova K, Vlcek J, Vytrisalova M, Maly J (2014) Healthy adherer effect \u2013 the pitfall in the interpretation of the effect of medication adherence on health outcomes. J Eval Clin Pract 20:111\u2013116. https:\/\/doi.org\/10.1111\/jep.12095","journal-title":"J Eval Clin Pract"},{"key":"1259_CR41","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ophtha.2013.11.038","volume":"121","author":"JD Stein","year":"2014","unstructured":"Stein JD, Lum F, Lee PP, Rich WL 3rd, Coleman AL (2014) Use of health care claims data to study patients with ophthalmologic conditions. Ophthalmology 121:1134\u20131141. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.038","journal-title":"Ophthalmology"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-021-01259-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T14:08:14Z","timestamp":1642428494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-021-01259-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s00774-021-01259-6","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Sungkyunkwan University\u2019s Institutional Review Board (SKKU-IRB- 2018\u201311-004), which waived the requirement for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This manuscript has been approved by all co-authors and has not been published before.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}